TABLE 2.

Characteristics of included patients.

No	Study	Male/Female	Mean age (years)	Median time from diagnosis (years)	Lines of prior treatment	Prior ASCT (%)	High-risk cytogenetics (%)	Extramedullary disease (%)	ECOG≥3 level (%)	ISS ≥3 level (%)	mAb exposed (%)	BCMA positivity requirement at enrollment (%)
1	Lin Y	—	61	5	6	97	45	27	—	—	90	—
2	Jennifer N. Brudno	—	—	—	9.5	75	40	—	—	—	44	—
3	Hao S	13/11	60.1	3.5	4.5	42	38	42	33	38	21	91.3
4	Alsina M	—	62	—	6	85	40	—	—	—	72	—
5	Wan-Hong Zhao	45/29	54.5	4	3	24	36	30	16	28	—	—
6	Sham Mailankody	—	53	4	10	88	50	—	—	—	—	—
7	Kumar SK	—	59	3.9	6	57	64	36	—	—	—	—
8	Sham Mailankody	—	—	—	6	—	82	—	—	—	9	—
9	Di Wang	10/8	53.5	2.6	4	33	39	—	—	0	39	83
10	Shwetha H. Manjunath	16/9	58	4.6	7	92	96	28	—	—	76	—
11	Damian J. Green	—	63	—	8	71	71	—	—	—	—	—
12	Jesus G Berdeja MD	57/40	61	5.9	6	90	24	—	4	14	84	>50% (57/62)
13	Nikhil C. Munshi	76/52	61	6	6	78	78	78	67	76	—	>50% (85/109)
14	XiaoYuan, Zhang	12/9	55	—	5	38	86	24	—	38	—	—
15	Juan Du	26/23	57	2.7	4	28	43	22	41	27	9	46
16	Xiaoyan Qu	17/14	61	—	4	23	48	10	0	16	23	49
17	Chen W	—	54	—	6	71	36	14	—	—	—	—
18	Costello CL	29/14	60	—	7	58	—	—	—	—	—	—
19	Frigault MJ	—	66	—	5	—	89	67	—	—	—	—
20	Hu Y	—	62.5	—	—	—	—	—	—	—	—	—
21	Chunrui Li	17/13	55	3.7	4	37	80	47	—	29	13	93

Abbreviations: ASCT, autologous stem cell transplant; ECOG, eastern cooperative oncology group; ISS, international staging system.